The unfolded protein response as a target for anticancer therapeutics

M Wang, ME Law, RK Castellano, BK Law - Critical reviews in oncology …, 2018 - Elsevier
The endoplasmic reticulum (ER) is an essential organelle in eukaryotic cells, responsible
for protein synthesis, folding, sorting, and transportation. ER stress is initiated when the …

Cyclin-dependent kinase inhibitors as anticancer therapeutics

ME Law, PE Corsino, S Narayan, BK Law - Molecular pharmacology, 2015 - ASPET
Cyclin-dependent kinases (CDKs) have been considered promising drug targets for a
number of years, but most CDK inhibitors have failed rigorous clinical testing. Recent studies …

Loss of sirtuin 1 and mitofusin 2 contributes to enhanced ischemia/reperfusion injury in aged livers

…, CE Miney, S Pierre Louis, BK Law, ME Law… - Aging cell, 2018 - Wiley Online Library
Ischemia/reperfusion (I/R) injury is a causative factor contributing to morbidity and mortality
during liver resection and transplantation. Livers from elderly patients have a poorer recovery …

[HTML][HTML] Repurposing tranexamic acid as an anticancer agent

ME Law, BJ Davis, AF Ghilardi, E Yaaghubi… - Frontiers in …, 2022 - frontiersin.org
Tranexamic Acid (TA) is a clinically used antifibrinolytic agent that acts as a Lys mimetic to
block binding of Plasminogen with Plasminogen activators, preventing conversion of …

Multidisciplinary management of acromegaly: a consensus

…, KKY Ho, AG Ioachimescu, S Lamberts, E Laws… - Reviews in Endocrine …, 2020 - Springer
The 13th Acromegaly Consensus Conference was held in November 2019 in Fort
Lauderdale, Florida, and comprised acromegaly experts including endocrinologists and …

DR5 disulfide bonding as a sensor and effector of protein folding stress

ME Law, ZM Dulloo, SR Eggleston, GP Takacs… - bioRxiv, 2024 - biorxiv.org
New agents are needed that selectively kill cancer cells without harming normal tissues. The
TRAIL ligand and its receptors, DR5 and DR4, exhibit cancer-selective toxicity, but TRAIL …

Clinical review: the strategy of immediate reoperation for transsphenoidal surgery for Cushing's disease

M Locatelli, ML Vance, ER Laws - The Journal of Clinical …, 2005 - academic.oup.com
Context: Transsphenoidal surgery is currently the primary therapeutic option for Cushing’s
disease. Despite considerable initial success, 10–30% of patients fail to achieve lasting …

Late recurrences of Cushing's disease after initial successful transsphenoidal surgery

…, MO Thorner, L Katznelson, ER Laws Jr - The Journal of …, 2008 - academic.oup.com
Context: Few studies have systematically analyzed the long-term recurrence rates of Cushing’s
disease after initial successful transsphenoidal surgery. Setting: This was a retrospective …

Endoscopic transsphenoidal surgery for acromegaly: remission using modern criteria, complications, and predictors of outcome

…, MO Thorner, JC Marshall, ER Laws Jr… - The Journal of …, 2011 - academic.oup.com
Context: Despite the growing application of endoscopic transsphenoidal surgery (ETSS),
outcomes for GH adenomas are not clearly defined. Objective: We reviewed our experience …

Carbon cycling in primary production bottle incubations: inferences from grazing experiments and photosynthetic studies using 14C and 18O in the Arabian Sea

EA Laws, MR Landry, RT Barber, L Campbell… - Deep Sea Research …, 2000 - Elsevier
Estimates of photosynthesis based on the incorporation of 14 C -labeled inorganic carbon
into particulate carbon were compared to estimates of gross photosynthesis based on net O 2 …